| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptability of tetanus toxoid vaccine by pregnant women in two health centres in Abidjan (Ivory Coast)
|
Ymba, Awa
|
|
2003
|
21 |
24 |
p. 3497-3500
4 p.
|
artikel
|
| 2 |
Antibody protection: passive immunization of neonates against oral AIDS virus challenge
|
Ruprecht, Ruth M
|
|
2003
|
21 |
24 |
p. 3370-3373
4 p.
|
artikel
|
| 3 |
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
|
Piedra, Pedro A.
|
|
2003
|
21 |
24 |
p. 3479-3482
4 p.
|
artikel
|
| 4 |
Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood
|
Holt, P.G.
|
|
2003
|
21 |
24 |
p. 3432-3435
4 p.
|
artikel
|
| 5 |
Editorial Board/Aims and Scope
|
|
|
2003
|
21 |
24 |
p. IFC-
1 p.
|
artikel
|
| 6 |
Effect of maternal antibodies on the infant immune response
|
Glezen, W.Paul
|
|
2003
|
21 |
24 |
p. 3389-3392
4 p.
|
artikel
|
| 7 |
Ex vivo human placenta models: transport of immunoglobulin G and its subclasses
|
Malek, Antoine
|
|
2003
|
21 |
24 |
p. 3362-3364
3 p.
|
artikel
|
| 8 |
Forthcoming events organized by the Merieux foundation
|
|
|
2003
|
21 |
24 |
p. I-
1 p.
|
artikel
|
| 9 |
How immune mechanisms are affected by pregnancy
|
Luppi, Patrizia
|
|
2003
|
21 |
24 |
p. 3352-3357
6 p.
|
artikel
|
| 10 |
Immunization of pregnant women: reproductive, medical and societal risks
|
Brent, Robert L.
|
|
2003
|
21 |
24 |
p. 3413-3421
9 p.
|
artikel
|
| 11 |
Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine
|
Baker, Carol J.
|
|
2003
|
21 |
24 |
p. 3468-3472
5 p.
|
artikel
|
| 12 |
Maternal immunisation in developing countries
|
Greenwood, Brian
|
|
2003
|
21 |
24 |
p. 3436-3441
6 p.
|
artikel
|
| 13 |
Maternal immunization and malaria in pregnancy
|
Duffy, Patrick E.
|
|
2003
|
21 |
24 |
p. 3358-3361
4 p.
|
artikel
|
| 14 |
Maternal immunization: US FDA regulatory considerations
|
Gruber, Marion F.
|
|
2003
|
21 |
24 |
p. 3487-3491
5 p.
|
artikel
|
| 15 |
Maternal immunization with Haemophilus influenzae type b vaccines in different populations
|
Englund, Janet A
|
|
2003
|
21 |
24 |
p. 3455-3459
5 p.
|
artikel
|
| 16 |
Maternal immunization with inactivated influenza vaccine: rationale and experience
|
Englund, Janet A.
|
|
2003
|
21 |
24 |
p. 3460-3464
5 p.
|
artikel
|
| 17 |
Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines
|
Quiambao, B.P.
|
|
2003
|
21 |
24 |
p. 3451-3454
4 p.
|
artikel
|
| 18 |
Materno-fetal transmission of autoimmune disease
|
Hughes, Graham
|
|
2003
|
21 |
24 |
p. 3426-3427
2 p.
|
artikel
|
| 19 |
Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life
|
Gans, Hayley
|
|
2003
|
21 |
24 |
p. 3398-3405
8 p.
|
artikel
|
| 20 |
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants
|
Siegrist, Claire-Anne
|
|
2003
|
21 |
24 |
p. 3406-3412
7 p.
|
artikel
|
| 21 |
Mucosal immunity: integration between mother and the breast-fed infant
|
Brandtzaeg, Per
|
|
2003
|
21 |
24 |
p. 3382-3388
7 p.
|
artikel
|
| 22 |
Non-genetic inheritable potential of maternal antibodies
|
Lemke, Hilmar
|
|
2003
|
21 |
24 |
p. 3428-3431
4 p.
|
artikel
|
| 23 |
Pertussis: an important target for maternal immunization
|
Edwards, Kathryn M.
|
|
2003
|
21 |
24 |
p. 3483-3486
4 p.
|
artikel
|
| 24 |
Placental transport of immunoglobulin G
|
Simister, Neil E.
|
|
2003
|
21 |
24 |
p. 3365-3369
5 p.
|
artikel
|
| 25 |
Pneumococcal conjugate vaccines as maternal and infant immunogens: challenges of maternal recruitment
|
Daly, Kathleen A.
|
|
2003
|
21 |
24 |
p. 3473-3478
6 p.
|
artikel
|
| 26 |
Protection of newborns through maternal immunization
|
Vicari, Marissa
|
|
2003
|
21 |
24 |
p. 3351-
1 p.
|
artikel
|
| 27 |
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
|
Munoz, Flor M.
|
|
2003
|
21 |
24 |
p. 3465-3467
3 p.
|
artikel
|
| 28 |
Session IV. Ethical, liability and regulatory issues
|
Glezen, W.Paul
|
|
2003
|
21 |
24 |
p. 3501-3502
2 p.
|
artikel
|
| 29 |
Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea
|
Lehmann, Deborah
|
|
2003
|
21 |
24 |
p. 3446-3450
5 p.
|
artikel
|
| 30 |
Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative
|
Vandelaer, J.
|
|
2003
|
21 |
24 |
p. 3442-3445
4 p.
|
artikel
|
| 31 |
The impact of maternal infection or immunization on early-onset autoimmune diabetes
|
Goldman, Michel
|
|
2003
|
21 |
24 |
p. 3422-3425
4 p.
|
artikel
|
| 32 |
The influence of mastitis on antibody transfer to infants through breast milk
|
Filteau, Suzanne
|
|
2003
|
21 |
24 |
p. 3377-3381
5 p.
|
artikel
|
| 33 |
The influence of maternal immunization on light chain response to Haemophilus influenzae type b vaccine
|
Nahm, Moon H
|
|
2003
|
21 |
24 |
p. 3393-3397
5 p.
|
artikel
|
| 34 |
Transfer of antibody via mother’s milk
|
Van de Perre, Philippe
|
|
2003
|
21 |
24 |
p. 3374-3376
3 p.
|
artikel
|
| 35 |
Vaccines in Argentina: a regulatory view
|
Pérez, A.C
|
|
2003
|
21 |
24 |
p. 3492-3496
5 p.
|
artikel
|
Tijdschrift beschrijving